Natural experimental evidence supports the real-world effectiveness of ticagrelor
On January 8th, 2025, HEFUU director Professor Erik Grönqvist (Dept. of Medical Sciences, Uppsala University) and HEFUU affiliate Associate Professor Jonathan Siverskog (Linköping University) provided a response to Doubts over landmark heart drug trial: ticagrelor PLATO study, an article published in the BMJ. For the full text of the response see: https://www.bmj.com/content/387/bmj.q2550/rr-0